This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Register
Menu
Register

Jordon Wang, PhD
COO and SVP of Technology Development at AvantGen
Speaker

Profile

Dr. Jordon Wang is the Chief Operating Officer and Senior Vice President of Technology Development at AvantGen. The team is dedicated in accelerating antibody-based therapeutics for their scientific partners by using innovative platforms. Prior to joining AvantGen, Jordon served as VP of Technology Development and VP of Antibody Discovery at LakePharma, now part of Curia. He earned a B.S. in Biological Sciences and a Ph.D. in Cancer Biology at Stanford University.

Agenda Sessions

  • Engineering Unique Properties in Next-Gen Antibody Therapies

    , 1:45pm
    View Session

At this event

Prev
Next
Sally Ward, PhD
Professor and Director
University of Southampton

See Jordon at Antibody Engineering & Therapeutics US

Register